Showing results (261-270 of 273) with videos related to
Sort By:
Pageof 28
Journal of Medicinal Chemistry|August 1, 1979
N-Alkyl derivatives of (+/-)-alpha-methyldopamineJ G Cannon, Z Perez, J P Long, et al.Neuroreport|April 11, 2000
Cerebellar hypoactivity in frequent marijuana usersR I Block, D S O'Leary, R D Hichwa, et al.Journal of Medicinal Chemistry|February 1, 1981
5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actionsJ G Cannon, A N Brubaker, J P Long, et al.Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1981
Dopamine receptor stimulating activity of 5-hydroxy-6-methyl-2-aminotetralin derivativesT Verimer, J P Long, R K Bhatnagar, et al.Pharmaceutical Research|June 1, 1988
Structure-activity relationship studies of hemicholinium (HC-3) congenersJ G Cannon, T M Lee, Y Chang, et al.Optics Express|July 1, 2010
An integrated surface-plasmon sourceC S Kim, I Vurgaftman, R A Flynn, et al.World Journal of Urology|January 1, 1994
The use of molecular genetic analysis in the diagnosis of renal cell carcinomaJ P Long, P Anglard, J R Gnarra, et al.AJNR. American Journal of Neuroradiology|September 15, 2022
Cellular Density in Adult Glioma, Estimated with MR Imaging Data and a Machine Learning Algorithm, Has Prognostic Power Approaching World Health Organization Histologic Grading in a Cohort of 1181 PatientsE D H Gates, D Suki, A Celaya, et al.European Journal of Pharmacology|April 1, 1979
Dopaminergic effects of non-hydroxylated rigid analogs of apomorphineD B Rusterholz, J P Long, J R Flynn, et al.Optics Express|June 7, 2011
A room-temperature semiconductor spaser operating near 1.5 μmR A Flynn, C S Kim, I Vurgaftman, et al.Pageof 28